Considering the important role of INDY (SLC13A5) in metabolism, INDY has become a particularly attractive target for the treatment of conditions such as obesity, diabetes, and cardiovascular diseases, (Birkenfeld et al., 2011; Rogina 2017; Willmes et al., 2018). Here, SLC13A5 is linked to obesity disorder.